Hughes E A, Hammond C, Cresswell P
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510, USA.
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1896-901. doi: 10.1073/pnas.94.5.1896.
N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL), which reversibly inhibits the proteasome in addition to other proteases, and a more specific irreversible inhibitor of the proteasome, lactacystin, were found to cause the accumulation of major histocompatibility complex (MHC) class I heavy chains in the cytosol of the beta2-microglobulin-deficient cell line Daudi and the TAP-deficient cell line .174. These cell lines, which are severely impaired in their ability to fold MHC class I heavy chain, showed an accumulation of soluble class I heavy chains at different rates over a period of hours in the presence of LLnL. The accumulation of soluble class I heavy chains in the presence of either LLnL or lactacystin was easily revealed in Daudi and .174 but almost undetectable in a Daudi transfectant expressing beta2-microglobulin and in 45.1, the wild-type parent of .174. The soluble class I heavy chain was also found to be devoid of its N-linked glycan and to be located in the cytosol. When the gene for ICP47, a herpes simplex virus protein that blocks the translocation of peptides into the endoplasmic reticulum, was transfected into 45.1, a similar accumulation of soluble MHC class I heavy chain was detectable. These data suggest that in cells where the MHC class I molecule is unable to assemble properly, the misfolded heavy chain is removed from the endoplasmic reticulum to the cytosol, deglycosylated, and degraded by the proteasome.
N-乙酰-L-亮氨酰-L-亮氨酰-L-正亮氨酸醛(LLnL),除了能抑制其他蛋白酶外,还能可逆性抑制蛋白酶体;以及一种更具特异性的蛋白酶体不可逆抑制剂乳胞素,它们被发现会导致主要组织相容性复合体(MHC)I类重链在β2-微球蛋白缺陷细胞系Daudi和TAP缺陷细胞系174的胞质溶胶中积累。这些细胞系在折叠MHC I类重链的能力上严重受损,在LLnL存在的情况下,数小时内可溶性I类重链以不同速率积累。在Daudi和174中,LLnL或乳胞素存在时可溶性I类重链的积累很容易被检测到,但在表达β2-微球蛋白的Daudi转染细胞和174的野生型亲本45.1中几乎检测不到。还发现可溶性I类重链没有其N-连接聚糖,且位于胞质溶胶中。当将单纯疱疹病毒蛋白ICP47(一种阻止肽转运到内质网的蛋白)的基因转染到45.1中时,可溶性MHC I类重链也有类似的积累。这些数据表明,在MHC I类分子无法正确组装的细胞中,错误折叠的重链会从内质网被转运到胞质溶胶,去糖基化,并被蛋白酶体降解。